$0.05 EPS Expected for Denbury Resources Inc. (DNR)

Jeannie Matthews
January 28, 2018

Elm Ridge Management Llc bought 3.86M shares as the company's stock declined 45.31% while stock markets rallied. After a recent check, Denbury Resources Inc (NYSE: DNR) stock is found to be 3.99% volatile for the week, while 5.44% volatility is recorded for the month. Barclays Capital downgraded Denbury Resources Inc. The stock had a trading volume of 4,749,828 shares, compared to its average volume of 8,840,000.

Denbury Resources Inc. (NYSE:DNR) reported its EPS in the last quarter as $0.04/Share beating the analyst estimate of $0.01/Share by a difference of $0.03.

Sailingstone Capital Partners Llc decreased its stake in Denbury Res Inc (DNR) by 1.22% based on its latest 2017Q3 regulatory filing with the SEC. The stock increased 1.40% or $0.17 during the last trading session, reaching $12.69. About 674,875 shares traded. Waste Management, Inc. (NYSE:WM) has risen 16.03% since January 27, 2017 and is uptrending.

Investors sentiment increased to 1.52 in 2017 Q3. Its down 0.26, from 1.59 in 2017Q2. Following last close company's stock, is 13.66% above their SMA 50 and -1.58% below the 52-week high. 29 funds opened positions while 51 raised stakes. Perella Weinberg Cap Mngmt Lp owns 0.09% invested in Dynegy Inc.

Among new and sold out positions, 23 holders initiated new positions by a total of 6.64 million shares and 22 holders exited their positions by a total of 11.08 million shares. Deutsche National Bank & Trust Ag reported 0.01% of its portfolio in Intercept Pharmaceuticals, Inc. Denbury Resources Inc.'s institutional ownership is 83.5%, while its institutional transactions stand at -0.26%. Morgan Stanley reported 618,745 shares. Numeric Investors Limited Liability Com stated it has 1.23 million shares. Rhumbline Advisers holds 0% or 19,939 shares in its portfolio. Manufacturers Life Insurance The has 0% invested in Dynegy Inc. (NASDAQ:ICPT). 40,300 were accumulated by Ny State Common Retirement Fund. Schwab Charles Inv Mngmt Inc accumulated 0% or 48,529 shares. 321.52 million shares or 7.26% less from 346.71 million shares in 2017Q2 were reported. About 4.75 million shares traded. Profund Advsrs owns 7,382 shares for 0.02% of their portfolio. Empyrean Prns Lp accumulated 1.31 million shares. Four research analysts have rated the stock with a sell rating, five have given a hold rating, two have issued a buy rating and one has assigned a strong buy rating to the company. Therefore 38% are positive. Intercept Pharmaceuticals has $423 highest and $50.0 lowest target.

Antonio Conte chuckles over Chelsea's historic trend
Chelsea manager Antonio Conte is keeping his head down amid reports that there is a break in relations with Blues leadership. Conte says he predicted a hard campaign last summer, when he said Chelsea must avoid a "Mourinho season".

Showalter: Machado To Move From 3B To Shortstop
Hardy, Showalter believes the Orioles will be better defensively if the slick-fielding Machado plays in the middle of the infield. Manny Machado will get his wish in 2018 when the Baltimore Orioles move the three-time All-Star to shortstop.

Incyte (INCY) Receives "Market Perform" Rating from Citigroup
Rock Springs Capital Mngmt Ltd Partnership holds 0.93% of its portfolio in Incyte Corporation (NASDAQ:INCY) for 173,000 shares. The collective rating of 2 for Incyte Corporation (NASDAQ:INCY) also leans strongly towards the neutral end of the spectrum.

On the other hand the company has Relative Strength Index (RSI 14) of 72.58 along with Average True Range (ATR 14) of 0.12, Consequently Denbury Resources (NYSE:DNR)'s weekly and monthly volatility is 3.64%, 5.06% respectively. Denbury Resources Inc. had 38 analyst reports since July 22, 2015 according to SRatingsIntel. Wells Fargo maintained the shares of ETR in report on Wednesday, October 25 with "Outperform" rating. The stock of Denbury Resources Inc. (NYSE:DNR) has "Sell" rating given on Friday, October 2 by UBS. (NYSE:DNR) has "Hold" rating given on Thursday, August 24 by RBC Capital Markets. (NYSE:DYN) earned "Neutral" rating by SunTrust on Monday, March 7. Cantor Fitzgerald maintained Intercept Pharmaceuticals, Inc. As per Tuesday, April 12, the company rating was upgraded by Bank of America. The rating was maintained by RBC Capital Markets with "Hold" on Thursday, September 28. As per Tuesday, February 21, the company rating was maintained by Wedbush. The company was downgraded on Monday, February 22 by Johnson Rice.

Analysts await Intercept Pharmaceuticals, Inc. Likewise, the upbeat performance for the last quarter was 134.26% and for the full year it was -31.99%. The hedge fund run by Ron Gutfleish held 4.76 million shares of the oil & gas production company at the end of 2017Q3, valued at $6.38M, up from 900,000 at the end of the previous reported quarter.

In the latest week Denbury Resources Inc. The company has market cap of $3.87 billion. The firm primarily focuses on enhanced oil recovery utilizing carbon dioxide. It now has negative earnings. It holds properties located in Mississippi, Texas, Louisiana, and Alabama in the Gulf Coast region; and in Montana, North Dakota, and Wyoming in the Rocky Mountain region.

The bad news is analysts don't believe there's a room for Denbury Resources Inc. This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell. Therefore 8% are positive. ValuEngine cut Denbury Resources from a "hold" rating to a "sell" rating in a research note on Sunday, December 31st.

The average 1-year price target for Denbury Resources Inc. (NYSE:DNR) on Tuesday, April 26 with "Sector Perform" rating. As per Thursday, July 13, the company rating was maintained by Stifel Nicolaus. The firm has "Hold" rating given on Wednesday, December 20 by RBC Capital Markets. The company presently has an average rating of Hold and a consensus target price of $2.13. As per Tuesday, January 16, the company rating was upgraded by Mizuho.

Other reports by

Discuss This Article

FOLLOW OUR NEWSPAPER